Electrophoresis is a technique, which is used to separate DNA, RNA, or protein molecules according to their size and electrical charge. The molecules are moved by an electric current through a gel or other matrix. Smaller molecules can move more quickly than larger molecules thanks to pores in the gel or matrix that act as a sieve. Standards of known sizes are separated on the same gel and compared to the sample to determine the size of the molecules in the sample. In recent years, the demand for electrophoresis has risen dramatically during the recent years, which is mainly due to the rising cases of cancer, infectious disease, and genetic disorders. For instance, as per the data of GLOBOCAN, about 19.2 Million newly diagnosed cancer cases were observed in the year 2020 and this number is expected to reach 21.6 Million by the year 2025.

Access a sample copy of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=31986

The Electrophoresis Market is expected to grow at a steady rate of around 6% owing to the rising cases of cancer, infectious disease, and genetic disorders coupled with the increasing investments in genomic research and rising number of research-industry collaborations. Major companies in the market are offering wide range of portfolio of consumables, instruments, and software for electrophioresis along with the quantification of protein. For instance, in September 2020, Promega launched Spectrum Compact Capillary Electrophoresis System, which is a Benchtop DNA analysis instrument capable of Sanger sequencing and fragment analysis at the bench. It is developed in the collaboration with Hitachi High-Tech.

For a detailed analysis of the Global Electrophoresis Market browse through– https://univdatos.com/report/electrophoresis-market/

Based on type, the market is segmented into electrophoresis systems, electrophoresis reagents, gel documentation systems and software, and imaging. The electrophoresis reagents segment is dominating the market and is expected to grow significantly during the forecast period owing to the growing adoption of the consumables coupled with the increasing application of electrophoresis in the field of proteomics, genomics, drug discovery, antibody production, personalized medicine etc. Along with this, the market for electrophoresis is expanding due to factors including the rising frequency of chronic diseases and partnerships and collaborations between top companies and academic institutions. For instance, in June 2021, Thermo Fisher Scientific signed an agreement with Advanced Electrophoresis Solutions Ltd with an aim of accelerating therapeutic development using Cutting-Edge Protein Analysis.

On the basis of application, the market is categorized into diagnostics, research, quality control, and others. Among these, the research segment held a significant share in the market in 2020. This is mainly due to the increasing application of electrophoresis in drug discovery, genomics, and proteonomics. Along with this, the growing adoption of next-generation sequencing and the identification of biomarkers is also expected to improve the adoption rate of electrophoresis and consumables in the research field.

For a detailed analysis of the Global Electrophoresis Market browse through– https://univdatos.com/report/electrophoresis-market/

Based on end user, the electrophoresis market is segmented into academic & research centers, pharmaceuticals & biotechnology, and hospitals & diagnostic centers. The academic & research centers held a significant share of the market and due to the high adoption of electrophoresis during the forecast period. This is mainly due to the rising adoption rate of electrophoresis in the field of drug discovery and development, genomics, proteomics, and precision medicine.

For a better understanding of the market adoption of the electrophoresis, the market is analyzed based on its worldwide presence in the countries such as North America (U.S., Canada, Rest of North America), Europe (Germany, U.K., France, Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of Asia-Pacific), Rest of World. APAC is anticipated to grow at a substantial CAGR during the forecast period. This is mainly due to the increasing research work related to proteomics & genomics research, rising awareness about personalized therapies, and increasing investments and collaborations in the pharmaceutical and biotechnology companies. Moreover, increasing research work related to monoclonal antibodies is further expected to support market growth. For instance, in 2019, about 27% of all the antibodies in China are related to recombinant antibodies, which is higher as compared to 13.8% in US. Further, the share of recombinant antibodies in total antibodies in Japan was about 15.5% during years 2019. So, increasing share of recombinant antibodies in the Asia-Pacific countries is attributing the growth of the electrophoresis market.

Some of the major players operating in the market include Bio-Rad Laboratories, GE Healthcare, Thermo Fisher Scientific, Inc., Danaher Corporation, Agilent Technologies, Merck Group, PerkinElmer, Inc., Harvard Bioscience, QIAGEN N.V., and Lonza Group Ltd.

Access a sample copy of the report browse through- https://univdatos.com/get-a-free-sample-form-php/?product_id=31986

Global Electrophoresis Market Segmentation

Market Insight, by Type

• Electrophoresis Systems

• Electrophoresis Reagents

• Gel Documentation Systems and Software

• Imaging

Market Insight, by Application

  • Diagnostics
  • Research
  • Quality Control
  • Others         

Market Insight, by End User

• Academic & Research Centers

• Pharmaceuticals & Biotechnology

• Hospitals & Diagnostic Centers

Market Insight, by Region

  • North America US
  •  Canada
  •  Rest of North America
  • EuropeGermany
  • United Kingdom
  • France
  • Italy
  • Spain
  • Rest of Europe
  • Asia-PacificChina
  • Japan
  • India
  • Rest of Asia-Pacific
  • Rest of the World

Top Company Profiles

• Bio-Rad Laboratories, Inc.

• GE Healthcare

• Thermo Fisher Scientific, Inc.

• Danaher Corporation

• Agilent Technologies

• Merck Group

• PerkinElmer, Inc.

• Harvard Bioscience

• QIAGEN N.V.

• Lonza Group Ltd.